Global investment in Cannabis

Medicinal Cannabis

LGC Capital is actively seeking to invest in totally legal medicinal cannabis companies. Our goal is to have a global footprint wherever cannabis is or is becoming legal.

Cannabis Prodution Facilities

We are investing internationally in facilities that allow for large scale cultivation of cannabis and production of legal products within regulatory environments that allow such activity.

Other Cannabis Investments

We have investments in a growing number of initiatives that will use legal cannabis products or associated to the development of the global cannabis market. We see tremendous growth opportunities in the fast growing Food & Beverage, Pet Products and Cosmetics sectors.

Medicinal Cannabis

Cannabis has been used for various purposes over a long period of time and is known to be free of many of the serious side effects caused by other drugs.

There is growing evidence that Medical Cannabis can benefit patients in a variety of clinical settings including:

  • Epilepsy
  • Chronic Pain
  • Multiple Sclerosis
  • Palliative Care
  • Cancer treatment induced nausea, appetite loss and sleep disturbance

Source: Little Green Pharma

Bringing Cannabis based F&B products to life

Increasingly, marijuana is seen as a functional food, with purported health benefits far outnumbering what consumers can get from kale, turmeric or kombucha.
(Source: Forbes)

Building legalized cannabis production facilities

A primary focus for LGC Capital is the identification of and investment in exciting growth opportunities around the world that will enable the production of large scale cannabis farming at the lowest possible cost base and help provide the much needed working capital for companies to build their farming and production facilities to meet the increasing demand for cannabis products as jurisdictions around the world legalise the use of cannabis for medicinal purposes.

We currently have a significant interest in Little Green Pharma, which is one of Australia’s only licenced growers, and we are funding and building a new state-of-the-art fully integrated facility in Montreal in Quebec, Canada. We are also actively pursuing large scale low cost growing opportunities in southern Africa and Jamaica and we see Europe and Asia as a massive target market for LGC for explosive growth.

Early stage investments are our specialty and we look forward to actively and rapidly adding new investments to our growing global portfolio. The world is our stage and we want to think outside the box.

LGC aims to grow within its portfolio one of the largest accumulations of cannabis plantations in the world. Super low-cost production across vast acreages is our goal, so that we can be a major supplier to licenced processors and end users. By being a global player, we can cross-pollinate each company’s bespoke growing, processing, logistics, marketing and distribution skills from people who really know their science.

Where do we see things heading…

Whilst there is currently a lot of activity globally around Cannaboid products, particularly in medicine, we see a very bright future for the industry.  At LGC Capital we see great potential growth in cosmetics, all sorts of clothing including swimwear plus many food and drink products including chocolate, soft drinks and alcoholic beverages.  The future is bright and LGC looks forward to being an active player and leader in this industry.

news from around the globe

Cannabis-related businesses constitute one of the fastest growing industries in the United States.

The medical marijuana market alone was worth $4.7 billion in 2016 and is expected to grow to $13.3 billion by 2020. Meanwhile, adult recreational sales amounted to $2.6 billion in 2016 and could reach $11.2 billion by 2020. With promising revenue and expansion across states, industries and product offerings, the marijuana industry has become an attractive opportunity for investors.

Forbes.comDuncan Rolph

Australian Cannabis Stocks Double After Relaxation of Export Rules

BloombergMatthew Burgess

Big Brewer Makes a Play for Marijuana Beverages
Corona brewer to invest nearly $200 million in Canadian marijuana grower, with plans to develop cannabis-infused drinks

The Wall Street JournalJennifer Maloney and David George-Cosh

Get in touch

5 + 2 = ?

If you have any questions about LGC Capital please feel free to get in touch.  If you are interested in investing in LGC Capital you can find information on how to do so here.  If you are interested in any specific investments we have made you can find out by sending us a message, we will respond as soon as possible.

For any other enquiries feel free to send us an email.